Long non-coding RNAs in ovarian cancer: expression profile and functional spectrum

References

• Torre LA, Trabert B, DeSantis CE, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68(4):284–296.
   PubMed Web of Science ®Google Scholar
• Norquist BM, Harrell MI, Brady MF, et al. Inherited mutations in women with ovarian carcinoma. JAMA Oncol. 2016;2(4):482–490.
   PubMed Web of Science ®Google Scholar
• Hunn J, Rodriguez GC. Ovarian cancer: etiology, risk factors, and epidemiology. Clin Obstet Gynecol. 2012;55(1):3–23.
   PubMed Web of Science ®Google Scholar
• Gong -T-T, Wu Q-J, Vogtmann E, et al. Age at menarche and risk of ovarian cancer: a meta-analysis of epidemiological studies. Int J Cancer. 2013;132(12):2894–2900.
   PubMed Web of Science ®Google Scholar
• Luan -N-N, Wu Q-J, Gong -T-T, et al. Breastfeeding and ovarian cancer risk: a meta-analysis of epidemiologic studies. Am J Clin Nutr. 2013;98(4):1020–1031.
   PubMed Web of Science ®Google Scholar
• Kolahdooz F, Ibiebele TI, van der Pols JC, et al. Dietary patterns and ovarian cancer risk. Am J Clin Nutr. 2008;89(1):297–304.
   PubMed Web of Science ®Google Scholar
• Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies. PLoS Med. 2012;9(4):e1001200.
   PubMed Web of Science ®Google Scholar
• Faber MT, Kjær SK, Dehlendorff C, et al. Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies. Cancer Causes Control. 2013;24(5):989–1004.
   PubMed Web of Science ®Google Scholar
• Klymenko Y, Nephew KP. Epigenetic crosstalk between the tumor microenvironment and ovarian cancer cells: a therapeutic road less traveled. Cancers (Basel). 2018;10(9):295.
   PubMed Web of Science ®Google Scholar
• Praestegaard C, Kjaer SK, Nielsen TS, et al. The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: a pooled analysis of 18 case-control studies. Cancer Epidemiol. 2016;41:71–79.
   PubMed Web of Science ®Google Scholar
• Darcy KM, Birrer MJ. Translational research in the gynecologic oncology group: evaluation of ovarian cancer markers, profiles, and novel therapies. Gynecol Oncol. 2010;117(3):429–439.
   PubMed Web of Science ®Google Scholar
• Lander ES. Initial impact of the sequencing of the human genome. Nature. 2011;470:187.
   PubMed Web of Science ®Google Scholar
• Consortium EP. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57–74.
   PubMed Web of Science ®Google Scholar
• Marchese FP, Raimondi I, Huarte M. The multidimensional mechanisms of long noncoding RNA function. Genome Biol. 2017;18(1):206.
   PubMed Web of Science ®Google Scholar
• Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409(6822):860–921.
   PubMed Web of Science ®Google Scholar
• Ransohoff JD, Wei Y, Khavari PA. The functions and unique features of long intergenic non-coding RNA. Nat Rev Mol Cell Biol. 2018;19(3):143–157.
   PubMed Web of Science ®Google Scholar
• Ma L, Bajic VB, Zhang Z. On the classification of long non-coding RNAs. RNA Biol. 2013;10(6):925–933.
   PubMed Web of Science ®Google Scholar
• Liu X, Lu Y, Zhu J, et al. A long noncoding RNA, Antisense IL-7, promotes inflammatory gene transcription through facilitating histone acetylation and switch/sucrose nonfermentable chromatin remodeling. J Iimmunol. 2019;203(6):1548–59. (Baltimore, Md: 1950).
   Web of Science ®Google Scholar
• Ritter N, Ali T, Kopitchinski N, et al. The lncRNA Locus handsdown regulates cardiac gene programs and is essential for early mouse development. Dev Cell. 2019;50(5):644–57.e8.
   PubMed Web of Science ®Google Scholar
• Li P, He J, Yang Z, et al. ZNNT1 long noncoding RNA induces autophagy to inhibit tumorigenesis of uveal melanoma by regulating key autophagy gene expression. Autophagy. 2019:1–14.
   Web of Science ®Google Scholar
• Cairns J, Ingle JN, Kalari KR, et al. The lncRNA MIR2052HG regulates ERalpha levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1. BCR. 2019;21(1):47.
   PubMedGoogle Scholar
• Gao Y, Li X, Zhi H, et al. Comprehensive characterization of somatic mutations impacting lncRNA expression for pan-cancer. Mol Ther Nucleic Acids. 2019;18:66–79.
   PubMedGoogle Scholar
• Yan H, Li H, Silva MA, et al. LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer. J Exp Clin Cancer Res. 2019;38(1):356.
   PubMed Web of Science ®Google Scholar
• Guo Q, Cheng Y, Liang T, et al. Comprehensive analysis of lncRNA-mRNA co-expression patterns identifies immune-associated lncRNA biomarkers in ovarian cancer malignant progression. Sci Rep. 2015;5:17683.
   PubMed Web of Science ®Google Scholar
• Li Z, Niu H, Qin Q, et al. lncRNA UCA1 mediates resistance to cisplatin by regulating the miR-143/FOSL2-signaling pathway in ovarian cancer. Mol Ther Nucleic Acids. 2019;17:92–101.
   PubMedGoogle Scholar
• Du Mee DJM, Ivanov M, Parker JP, et al. Efficient termination of nuclear lncRNA transcription promotes mitochondrial genome maintenance. eLife. 2018;7:e31989.
   Web of Science ®Google Scholar
• Martignetti JA, Brosius J. BC200 RNA: a neural RNA polymerase III product encoded by a monomeric Alu element. Proc Natl Acad Sci U S A. 1993;90(24):11563–11567.
   PubMed Web of Science ®Google Scholar
• Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009;458:223.
   PubMed Web of Science ®Google Scholar
• Deveson IW, Brunck ME, Blackburn J, et al. Universal alternative splicing of noncoding exons. Cell Syst. 2018;6(2):245–55.e5.
   PubMed Web of Science ®Google Scholar
• Shukla CJ, McCorkindale AL, Gerhardinger C, et al. High-throughput identification of RNA nuclear enrichment sequences. Embo J. 2018;37(6):e98452.
   PubMed Web of Science ®Google Scholar
• Gudenas BL, Wang L. Prediction of lncRNA subcellular localization with deep learning from sequence features. Sci Rep. 2018;8(1):16385.
   PubMedGoogle Scholar
• Novikova IV, Hennelly SP, Sanbonmatsu KY. Structural architecture of the human long non-coding RNA, steroid receptor RNA activator. Nucleic Acids Res. 2012;40(11):5034–5051.
   PubMed Web of Science ®Google Scholar
• Wilusz JE, JnBaptiste CK, Lu LY, et al. A triple helix stabilizes the 3ʹ ends of long noncoding RNAs that lack poly(A) tails. Genes Dev. 2012;26(21):2392–2407.
   PubMed Web of Science ®Google Scholar
• Fabbri M, Girnita L, Varani G, et al. Decrypting noncoding RNA interactions, structures, and functional networks. Genome Res. 2019;29(9):1377–1388.
   PubMed Web of Science ®Google Scholar
• Liu Z, Chen Z, Fan R, et al. Over-expressed long noncoding RNA HOXA11-AS promotes cell cycle progression and metastasis in gastric cancer. Mol Cancer. 2017;16(1):82.
   PubMedGoogle Scholar
• Sun M, Nie F, Wang Y, et al. LncRNA HOXA11-AS promotes proliferation and invasion of gastric cancer by scaffolding the chromatin modification factors PRC2, LSD1, and DNMT1. Cancer Res. 2016;76(21):6299.
   PubMed Web of Science ®Google Scholar
• Li X, Chen N, Zhou L, et al. Genome-wide target interactome profiling reveals a novel EEF1A1 epigenetic pathway for oncogenic lncRNA MALAT1 in breast cancer. Am J Cancer Res. 2019;9(4):714–729.
   PubMed Web of Science ®Google Scholar
• Hutchinson JN, Ensminger AW, Clemson CM, et al. A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains. BMC Genomics. 2007;8:39.
   PubMed Web of Science ®Google Scholar
• Krchňáková Z, Thakur PK, Krausová M, et al. Splicing of long non-coding RNAs primarily depends on polypyrimidine tract and 5′ splice-site sequences due to weak interactions with SR proteins. Nucleic Acids Res. 2018;47(2):911–928.
   Web of Science ®Google Scholar
• Raveendra BL, Swarnkar S, Avchalumov Y, et al. Long noncoding RNA GM12371 acts as a transcriptional regulator of synapse function. Proc Nat Acad Sci. 2018;115(43):E10197.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Rowley MJ, Böhmdorfer G, et al. A SWI/SNF chromatin-remodeling complex acts in noncoding RNA-mediated transcriptional silencing. Mol Cell. 2013;49(2):298–309.
   PubMed Web of Science ®Google Scholar
• Wu XS, Wang F, Li HF, et al. LncRNA-PAGBC acts as a microRNA sponge and promotes gallbladder tumorigenesis. EMBO Rep. 2017;18(10):1837–1853.
   PubMed Web of Science ®Google Scholar
• Chen J, Liu L, Wei G, et al. The long noncoding RNA ASNR regulates degradation of Bcl-2 mRNA through its interaction with AUF1. Sci Rep. 2016;6:32189.
   PubMed Web of Science ®Google Scholar
• Ribeiro DM, Zanzoni A, Cipriano A, et al. Protein complex scaffolding predicted as a prevalent function of long non-coding RNAs. Nucleic Acids Res. 2018;46(2):917–928.
   PubMed Web of Science ®Google Scholar
• Wang H, Fu Z, Dai C, et al. LncRNAs expression profiling in normal ovary, benign ovarian cyst and malignant epithelial ovarian cancer. Sci Rep. 2016;6:38983.
   PubMed Web of Science ®Google Scholar
• Nakagawa S, Shimada M, Yanaka K, et al. The lncRNA Neat1 is required for corpus luteum formation and the establishment of pregnancy in a subpopulation of mice. Development. 2014;141(23):4618–4627.
   PubMed Web of Science ®Google Scholar
• Xu X-F, Li J, Cao Y-X, et al. Differential expression of long noncoding RNAs in human cumulus cells related to embryo developmental potential: a microarray analysis. Reprod Sci. 2015;22(6):672–678.
   PubMed Web of Science ®Google Scholar
• Cuomo D, Porreca I, Ceccarelli M, et al. Transcriptional landscape of mouse-aged ovaries reveals a unique set of non-coding RNAs associated with physiological and environmental ovarian dysfunctions. Cell Death Discov. 2018;4(1):112.
   PubMedGoogle Scholar
• Li L, Ren F, Qi C, et al. Intermittent hypoxia promotes melanoma lung metastasis via oxidative stress and inflammation responses in a mouse model of obstructive sleep apnea. Respir Res. 2018;19(1):28.
   PubMedGoogle Scholar
• Giatromanolaki A, Koukourakis MI, Sivridis E, et al. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer. 2001;85(6):881–890.
   PubMed Web of Science ®Google Scholar
• Selvendiran K, Bratasz A, Kuppusamy ML, et al. Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3. Int J Cancer. 2009;125(9):2198–2204.
   PubMed Web of Science ®Google Scholar
• Ferdin J, Nishida N, Wu X, et al. HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcripts. Cell Death Differ. 2013;20(12):1675–1687.
   PubMed Web of Science ®Google Scholar
• Fish JE, Matouk CC, Yeboah E, et al. Hypoxia-inducible expression of a natural cis-antisense transcript inhibits endothelial nitric-oxide synthase. J Biol Chem. 2007;282(21):15652–15666.
   PubMed Web of Science ®Google Scholar
• Dong J, Xu J, Wang X, et al. Influence of the interaction between long noncoding RNAs and hypoxia on tumorigenesis. Tumour Biol. 2016;37(2):1379–1385.
   PubMedGoogle Scholar
• Zhou C, Ye L, Jiang C, et al. Long noncoding RNA HOTAIR, a hypoxia-inducible factor-1alpha activated driver of malignancy, enhances hypoxic cancer cell proliferation, migration, and invasion in non-small cell lung cancer. Tumour Biol. 2015;36(12):9179–9188.
   PubMedGoogle Scholar
• Wang Y, Huang Y, Liu H, et al. Long noncoding RNA CDKN2B-AS1 interacts with miR-411–3p to regulate ovarian cancer in vitro and in vivo through HIF-1a/VEGF/P38 pathway. Biochem Biophys Res Commun. 2019;514(1):44–50.
   PubMed Web of Science ®Google Scholar
• Zhang H, Yao B, Tang S, et al. LINK-A long non-coding RNA (lncRNA) participates in metastasis of ovarian carcinoma and upregulates hypoxia-inducible factor 1 (HIF1α). Med Sci Monit. 2019;25:2221–2227.
   PubMed Web of Science ®Google Scholar
• Kim A, Im M, Yim N-H, et al. Reduction of metastatic and angiogenic potency of malignant cancer by Eupatorium fortunei via suppression of MMP-9 activity and VEGF production. Sci Rep. 2014;4:6994.
   PubMed Web of Science ®Google Scholar
• Yim GW, Kim HJ, Kim LK, et al. Long Non-coding RNA HOXA11 antisense promotes cell proliferation and invasion and predicts patient prognosis in serous ovarian cancer. Cancer Res Treat. 2017;49(3):656–668.
   PubMed Web of Science ®Google Scholar
• Wang J, Xu W, He Y, et al. LncRNA MEG3 impacts proliferation, invasion, and migration of ovarian cancer cells through regulating PTEN. Inflammation Res. 2018;67(11):927–936.
   PubMed Web of Science ®Google Scholar
• Ling H, Spizzo R, Atlasi Y, et al. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res. 2013;23(9):1446–1461.
   PubMed Web of Science ®Google Scholar
• Huang S, Qing C, Huang Z, et al. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis. Diagn Pathol. 2016;11(1):49.
   PubMedGoogle Scholar
• Chen YG, Satpathy AT, Chang HY. Gene regulation in the immune system by long noncoding RNAs. Nat Immunol. 2017;18(9):962–972.
   PubMed Web of Science ®Google Scholar
• Wang X, Hu Y, Cui J, et al. Coordinated targeting of MMP-2/MMP-9 by miR-296-3p/FOXCUT exerts tumor-suppressing effects in choroidal malignant melanoma. Mol Cell Biochem. 2018;445(1–2):25–33.
   PubMed Web of Science ®Google Scholar
• Jiang M, Zhang S, Yang Z, et al. Self-recognition of an inducible host lncRNA by RIG-I feedback restricts innate immune response. Cell. 2018;173(4):906–19.e13.
   PubMed Web of Science ®Google Scholar
• Li J, Yang C, Li Y, et al. LncRNA GAS5 suppresses ovarian cancer by inducing inflammasome formation. Biosci Rep. 2018;38(2):BSR20171150.
   PubMedGoogle Scholar
• Zhao L, Ji G, Le X, et al. Long Noncoding RNA LINC00092 acts in cancer-associated fibroblasts to drive glycolysis and progression of ovarian cancer. Cancer Res. 2017;77(6):1369–1382.
   PubMed Web of Science ®Google Scholar
• Court F, Baniol M, Hagege H, et al. Long-range chromatin interactions at the mouse Igf2/H19 locus reveal a novel paternally expressed long non-coding RNA. Nucleic Acids Res. 2011;39(14):5893–5906.
   PubMed Web of Science ®Google Scholar
• Thorvaldsen JL, Duran KL, Bartolomei MS. Deletion of the H19 differentially methylated domain results in loss of imprinted expression of H19 and Igf2. Genes Dev. 1998;12(23):3693–3702.
   PubMed Web of Science ®Google Scholar
• Adriaenssens E, Lottin S, Dugimont T, et al. Steroid hormones modulate H19 gene expression in both mammary gland and uterus. Oncogene. 1999;18(31):4460–4473.
   PubMed Web of Science ®Google Scholar
• Li J, Huang Y, Deng X, et al. Long noncoding RNA H19 promotes transforming growth factor-beta-induced epithelial-mesenchymal transition by acting as a competing endogenous RNA of miR-370-3p in ovarian cancer cells. Onco Targets Ther. 2018;11:427–440.
   PubMed Web of Science ®Google Scholar
• Ohtsuka M, Ling H, Ivan C, et al. H19 Noncoding RNA, an independent prognostic factor, regulates essential Rb-E2F and CDK8-beta-catenin signaling in colorectal cancer. EBioMedicine. 2016;13:113–124.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Song L, He J, et al. Ectopic expressed long non-coding RNA H19 contributes to malignant cell behavior of ovarian cancer. Int J Clin Exp Pathol. 2015;8(9):10082–10091.
   PubMed Web of Science ®Google Scholar
• Lavie O, Edelman D, Levy T, et al. A phase 1/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian/peritoneal cancer. Arch Gynecol Obstet. 2017;295(3):751–761.
   PubMed Web of Science ®Google Scholar
• Rinn JL, Kertesz M, Wang JK, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 2007;129(7):1311–1323.
   PubMed Web of Science ®Google Scholar
• Liu XH, Sun M, Nie FQ, et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer. 2014;13:92.
   PubMed Web of Science ®Google Scholar
• Li P, Zhang X, Wang L, et al. lncRNA HOTAIR contributes to 5FU resistance through suppressing miR-218 and activating NF-kappaB/TS signaling in colorectal cancer. Mol Ther Nucleic Acids. 2017;8:356–369.
   PubMedGoogle Scholar
• Yu Y, Zhang X, Tian H, et al. Knockdown of long non-coding RNA HOTAIR increases cisplatin sensitivity in ovarian cancer by inhibiting cisplatin-induced autophagy. J Buon. 2018;23(5):1396–1401.
   PubMed Web of Science ®Google Scholar
• Ozes AR, Miller DF, Ozes ON, et al. NF-kappaB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer. Oncogene. 2016;35(41):5350–5361.
   PubMed Web of Science ®Google Scholar
• Li J, Yang S, Su N, et al. Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt/beta-catenin pathway in human ovarian cancer. Tumour Biol. 2016;37(2):2057–2065.
   PubMedGoogle Scholar
• Santiago L, Daniels G, Wang D, et al. Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment. Am J Cancer Res. 2017;7(6):1389–1406.
   PubMed Web of Science ®Google Scholar
• Ji P, Diederichs S, Wang W, et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003;22(39):8031–8041.
   PubMed Web of Science ®Google Scholar
• Guo C, Wang X, Chen LP, et al. Long non-coding RNA MALAT1 regulates ovarian cancer cell proliferation, migration and apoptosis through Wnt/beta-catenin signaling pathway. Eur Rev Med Pharmacol Sci. 2018;22(12):3703–3712.
   PubMed Web of Science ®Google Scholar
• Zhuang M, Zhao S, Jiang Z, et al. MALAT1 sponges miR-106b-5p to promote the invasion and metastasis of colorectal cancer via SLAIN2 enhanced microtubules mobility. EBioMedicine. 2019;41:286–298.
   PubMed Web of Science ®Google Scholar
• Tao F, Tian X, Ruan S, et al. miR-211 sponges lncRNA MALAT1 to suppress tumor growth and progression through inhibiting PHF19 in ovarian carcinoma. Faseb J. 2018;32(11);fj201800495RR.
   PubMed Web of Science ®Google Scholar
• Zhao K, Yang Y, Zhang G, et al. Regulation of the Mdm2-p53 pathway by the ubiquitin E3 ligase MARCH7. EMBO Rep. 2018;19(2):305–319.
   PubMed Web of Science ®Google Scholar
• Gao W, Thompson L, Zhou Q, et al. Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6. Cell Cycle (Georgetown, Tex). 2009;8(9):1444–1450.
   PubMed Web of Science ®Google Scholar
• Hu J, Zhang L, Mei Z, et al. Interaction of E3 Ubiquitin Ligase MARCH7 with long noncoding RNA MALAT1 and autophagy-related protein ATG7 promotes autophagy and invasion in ovarian cancer. Cell Physiol Biochem. 2018;47(2):654–666.
   PubMedGoogle Scholar
• Shi D, Zhang Y, Lu R, et al. The long non-coding RNA MALAT1 interacted with miR-218 modulates choriocarcinoma growth by targeting Fbxw8. Biomed Pharmacothe. 2018;97:543–550.
   PubMed Web of Science ®Google Scholar
• Brown CJ, Ballabio A, Rupert JL, et al. A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature. 1991;349(6304):38–44.
   PubMed Web of Science ®Google Scholar
• Kawakami T, Zhang C, Taniguchi T, et al. Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells. Oncogene. 2004;23(36):6163–6169.
   PubMed Web of Science ®Google Scholar
• Wang C, Qi S, Xie C, et al. Upregulation of long non-coding RNA XIST has anticancer effects on epithelial ovarian cancer cells through inverse downregulation of hsa-miR-214-3p. J Gynecol Oncol. 2018;29(6):e99.
   PubMed Web of Science ®Google Scholar
• Huang KC, Rao PH, Lau CC, et al. Relationship of XIST expression and responses of ovarian cancer to chemotherapy. Mol Cancer Ther. 2002;1(10):769–776.
   PubMed Web of Science ®Google Scholar
• Zeidler R, Joos S, Delecluse HJ, et al. Breakpoints of Burkitt’s lymphoma t(8;22) translocations map within a distance of 300 kb downstream of MYC. Genes Chromosomes Cancer. 1994;9(4):282–287.
   PubMed Web of Science ®Google Scholar
• Zou MF, Ling J, Wu QY, et al. Long non-coding RNA PVT1 functions as an oncogene in ovarian cancer via upregulating SOX2. Eur Rev Med Pharmacol Sci. 2018;22(21):7183–7188.
   PubMed Web of Science ®Google Scholar
• Shen SN, Li K, Liu Y, et al. Down-regulation of long noncoding RNA PVT1 inhibits esophageal carcinoma cell migration and invasion and promotes cell apoptosis via microRNA-145-mediated inhibition of FSCN1. Mol Oncol. 2019;13(12):2554–73.
   Web of Science ®Google Scholar
• Chen Y, Du H, Bao L, et al. LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214. Cancer Biol Med. 2018;15(3):238–250.
   PubMed Web of Science ®Google Scholar
• Luo J, Zhou J, Cheng Q, et al. Role of microRNA-133a in epithelial ovarian cancer pathogenesis and progression. Oncol Lett. 2014;7(4):1043–1048.
   PubMed Web of Science ®Google Scholar
• Yang Q, Yu Y, Sun Z, et al. Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer. Biomed Pharmacothe. 2018;106:61–67.
   PubMed Web of Science ®Google Scholar
• Wang XS, Zhang Z, Wang HC, et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res off J Am Assoc Cancer Res. 2006;12(16):4851–4858.
   PubMed Web of Science ®Google Scholar
• Wang J, Ye C, Liu J, et al. UCA1 confers paclitaxel resistance to ovarian cancer through miR-129/ABCB1 axis. Biochem Biophys Res Commun. 2018;501(4):1034–1040.
   PubMed Web of Science ®Google Scholar
• Hong HH, Hou LK, Pan X, et al. Long non-coding RNA UCA1 is a predictive biomarker of cancer. Oncotarget. 2016;7(28):44442–44447.
   PubMedGoogle Scholar
• Schneider C, King RM, Philipson L. Genes specifically expressed at growth arrest of mammalian cells. Cell. 1988;54(6):787–793.
   PubMed Web of Science ®Google Scholar
• Avgeris M, Tsilimantou A, Levis PK, et al. Loss of GAS5 tumour suppressor lncRNA: an independent molecular cancer biomarker for short-term relapse and progression in bladder cancer patients. Br J Cancer. 2018;119(12):1477–1486.
   PubMed Web of Science ®Google Scholar
• Zhao H, Yu H, Zheng J, et al. Lowly-expressed lncRNA GAS5 facilitates progression of ovarian cancer through targeting miR-196-5p and thereby regulating HOXA5. Gynecol Oncol. 2018;151(2):345–355.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang J, Wang Y. Long noncoding RNA GAS5-AS1 suppresses growth and metastasis of cervical cancer by increasing GAS5 stability. Am J Transl Res. 2019;11(8):4909–4921.
   PubMed Web of Science ®Google Scholar
• Gao J, Liu M, Zou Y, et al. Long non-coding RNA growth arrest-specific transcript 5 is involved in ovarian cancer cell apoptosis through the mitochondria-mediated apoptosis pathway. Oncol Rep. 2015;34(6):3212–3221.
   PubMed Web of Science ®Google Scholar
• Long X, Song K, Hu H, et al. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis. J Exp Clin Cancer Res. 2019;38(1):345.
   PubMed Web of Science ®Google Scholar
• Yarmishyn AA, Batagov AO, Tan JZ, et al. HOXD-AS1 is a novel lncRNA encoded in HOXD cluster and a marker of neuroblastoma progression revealed via integrative analysis of noncoding transcriptome. BMC Genomics. 2014;15(Suppl 9):S7.
   PubMed Web of Science ®Google Scholar
• Wang H, Huo X, Yang XR, et al. STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4. Mol Cancer. 2017;16(1):136.
   PubMed Web of Science ®Google Scholar
• Xia H, Jing H, Li Y, et al. Long noncoding RNA HOXD-AS1 promotes non-small cell lung cancer migration and invasion through regulating miR-133b/MMP9 axis. Biomed Pharmacothe. 2018;106:156–162.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang W, Wang Y, et al. HOXD-AS1 promotes cell proliferation, migration and invasion through miR-608/FZD4 axis in ovarian cancer. Am J Cancer Res. 2018;8(1):170–182.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Dun Y, Zhou S, et al. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/beta-catenin signaling pathway. Biomed Pharmacothe. 2017;96:1216–1221.
   PubMed Web of Science ®Google Scholar
• Dong S, Wang R, Wang H, et al. HOXD-AS1 promotes the epithelial to mesenchymal transition of ovarian cancer cells by regulating miR-186-5p and PIK3R3. J Exp Clin Cancer Res. 2019;38(1):110.
   PubMedGoogle Scholar
• Liu F, Yang X, Geng M, et al. Targeting ERK, an Achilles’ Heel of the MAPK pathway, in cancer therapy. Acta Pharm Sin B. 2018;8(4):552–562.
   PubMed Web of Science ®Google Scholar
• Khaitan D, Dinger ME, Mazar J, et al. The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res. 2011;71(11):3852–3862.
   PubMed Web of Science ®Google Scholar
• Das MK, Furu K, Evensen HF, et al. Knockdown of SPRY4 and SPRY4-IT1 inhibits cell growth and phosphorylation of Akt in human testicular germ cell tumours. Sci Rep. 2018;8(1):2462.
   PubMedGoogle Scholar
• Li H, Liu C, Lu Z, et al. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer. Biomed Pharmacother. 2017;88:529–534.
   PubMed Web of Science ®Google Scholar
• Xie M, Nie F-Q, Sun M, et al. Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial-mesenchymal transition. J Transl Med. 2015;13:250.
   PubMed Web of Science ®Google Scholar
• Miyoshi N, Wagatsuma H, Wakana S, et al. Identification of an imprinted gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q. Genes Cells. 2000;5(3):211–220.
   PubMed Web of Science ®Google Scholar
• Wei GH, Wang X. lncRNA MEG3 inhibit proliferation and metastasis of gastric cancer via p53 signaling pathway. Eur Rev Med Pharmacol Sci. 2017;21(17):3850–3856.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wu N, Wang J, et al. LncRNA MEG3 inhibits cell proliferation and induces apoptosis in laryngeal cancer via miR-23a/APAF-1 axis. J Cell Mol Med. 2019;23(10):6708–19.
   Web of Science ®Google Scholar
• Wang J, Xu W, He Y, et al. LncRNA MEG3 impacts proliferation, invasion, and migration of ovarian cancer cells through regulating PTEN. Inflammation Res. 2018;67(11–12):927–936.
   PubMed Web of Science ®Google Scholar
• Sheng X, Li J, Yang L, et al. Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer. Oncol Rep. 2014;32(1):277–285.
   PubMed Web of Science ®Google Scholar
• Li J, Zhou D, Wang Z, et al. [Reversal effect of 5-aza-2-deoxycytidine on the maternally expressed gene 3 promoter hypermethylation and its inhibitory effect on the proliferation of epithelial ovarian cancer cells]. Zhonghua Zhong Liu Za Zhi. 2015;37(5):324–329.
   PubMedGoogle Scholar
• Mitra R, Chen X, Greenawalt EJ, et al. Decoding critical long non-coding RNA in ovarian cancer epithelial-to-mesenchymal transition. Nat Commun. 2017;8(1):1604.
   PubMed Web of Science ®Google Scholar
• Wang J-H, Hendry BM, Sharpe CC. Silencing genes in the kidney: antisense or RNA interference? Nephrol Dial Transplant. 2008;23(7):2115–2118.
   PubMed Web of Science ®Google Scholar
• Cheng Z, Guo J, Chen L, et al. A long noncoding RNA AB073614 promotes tumorigenesis and predicts poor prognosis in ovarian cancer. Oncotarget. 2015;6(28):25381–25389.
   PubMed Web of Science ®Google Scholar
• Gordon MA, Babbs B, Cochrane DR, et al. The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing. Mol Carcinog. 2019;58(2):196–205.
   PubMed Web of Science ®Google Scholar
• Rupaimoole R, Lee J, Haemmerle M, et al. Long noncoding RNA ceruloplasmin promotes cancer growth by altering glycolysis. Cell Rep. 2015;13(11):2395–2402.
   PubMed Web of Science ®Google Scholar
• Gubin MM, Zhang X, Schuster H, et al. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature. 2014;515:577.
   PubMed Web of Science ®Google Scholar
• Ranzani V, Arrigoni A, Rossetti G, et al. Next-generation sequencing analysis of long noncoding RNAs in CD4+ T cell differentiation. Methods Mol Biol. 2017;1514:173–185.
   PubMedGoogle Scholar
• Guo Q, Cheng Y, Liang T, et al. Comprehensive analysis of lncRNA-mRNA co-expression patterns identifies immune-associated lncRNA biomarkers in ovarian cancer malignant progression. Sci Rep. 2015;5:17683.
   PubMed Web of Science ®Google Scholar
• Simon MD. Capture hybridization analysis of RNA targets (CHART). In: Karen A, Roger B, Philip C, David DM, Erik S, and Koen V, Editors. Current protocols in molecular biology. John Wiley & Sons, Inc; 2013;101(1):21.25.1–25.16.
   Google Scholar
• Kuo YP, Ma CP, Chen HW, et al. A novel antisense RNA ASPACT confers multi-level suppression of PACT and associated signalling. RNA Biol. 2019;16(9):1263–1274.
   PubMed Web of Science ®Google Scholar
• Atianand MK, Hu W, Satpathy AT, et al. A long noncoding RNA lincRNA-EPS acts as a transcriptional brake to restrain inflammation. Cell. 2016;165(7):1672–1685.
   PubMed Web of Science ®Google Scholar
• Khurana E, Fu Y, Colonna V, et al. Integrative annotation of variants from 1092 humans: application to cancer genomics. Science. 2013;342(6154):1235587.
   PubMed Web of Science ®Google Scholar
• Guo L, Peng Y, Meng Y, et al. Expression profiles analysis reveals an integrated miRNA-lncRNA signature to predict survival in ovarian cancer patients with wild-type BRCA1/2. Oncotarget. 2017;8(40):68483–68492.
   PubMedGoogle Scholar
• Wang X, Han L, Zhou L, et al. Prediction of candidate RNA signatures for recurrent ovarian cancer prognosis by the construction of an integrated competing endogenous RNA network. Oncol Rep. 2018;40(5):2659–2673.
   PubMed Web of Science ®Google Scholar
• Ning L, Hu YC, Wang S, et al. Altered long noncoding RNAs and survival outcomes in ovarian cancer: A systematic review and meta-analysis (PRISMA Compliant). Medicine (Baltimore). 2018;97(32):e11481.
   PubMed Web of Science ®Google Scholar
• Lee GL, Dobi A, Srivastava S. Prostate cancer: diagnostic performance of the PCA3 urine test. Nat Rev Urol. 2011;8(3):123–124.
   PubMed Web of Science ®Google Scholar
• Qiu JJ, Lin XJ, Tang XY, et al. Exosomal metastasisassociated lung adenocarcinoma transcript 1 promotes angiogenesis and predicts poor prognosis in epithelial ovarian cancer. Int J Biol Sci. 2018;14(14):1960–1973.
   PubMed Web of Science ®Google Scholar
• Wu Q, Wu X, Ying X, et al. Suppression of endothelial cell migration by tumor associated macrophage-derived exosomes is reversed by epithelial ovarian cancer exosomal lncRNA. Cancer Cell Int. 2017;17:62.
   PubMed Web of Science ®Google Scholar
• Kolenda T, Rutkowski P, Michalak M, et al. Plasma lncRNA expression profile as a prognostic tool in BRAF-mutant metastatic melanoma patients treated with BRAF inhibitor. Oncotarget. 2019;10(39):3879–3893.
   PubMedGoogle Scholar
• Lee B, Mahmud I, Marchica J, et al. Integrated RNA and metabolite profiling of urine liquid biopsies for prostate cancer biomarker discovery. bioRxiv. 2019;599514.
   Google Scholar
• Palmirotta R, Lovero D, Cafforio P, et al. Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology. Ther Adv Med Oncol. 2018;10:1758835918794630.
   Web of Science ®Google Scholar
• Lalremmawia H, Tiwary BK. Identification of molecular biomarkers for ovarian cancer using computational approaches. Carcinogenesis. 2019;40(6):742–748.
   PubMed Web of Science ®Google Scholar
• Shatsky R, Parker BA, Bui NQ, et al. Next-generation sequencing of tissue and circulating tumor DNA: the UC San Diego Moores Center for personalized cancer therapy experience with breast malignancies. Mol Cancer Ther. 2019;18(5):1001–1011.
   PubMed Web of Science ®Google Scholar